Mortgage Blog

Truist's planned $750 million in costs cuts have put it on the right path to achieve greater efficiency, but that isn't the bank's top concern, an analyst says.

The FDA panel said oral phenylephrine, the decongestant in DayQuil, is thoroughly ineffective.

Lankford Wade is just four days on the job as CEO of UpStream, one of the Triad’s fastest growing startups, and he’s already planning rapid expansion. Former CEO and co-founder Sanjay Doddamani quietly left the company in April.

Hundreds of claims continue to come in.

Lazydays is seeking more capital after spending big on acquisitions and real estate in recent quarters.

A biotech startup using generative AI to create new, protein-based medicines has closed on a $273 million round as it looks to expand its reach.

The CFO who left bluebird bio last fall after nearly nine years has found a new roost. Plus other life sciences news you may have missed.

Nonprofit investors maintain that despite their similarities to venture capital firms, there are key differences. But the model also has drawbacks, including misaligned incentives.

The first-of-its-kind initiative has been years in the making and will address next-generation health care.

Chief Operating Officer Annie Erstling shared her insight on the intersection of home healthcare and technology and Forcura's growth.